Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Carmen P. Escalante, Edward B. Rubenstein & Kenneth V. I. Rolston. (1997) Outpatient Antibiotic Therapy for Febrile Episodes in Low-Risk Neutropenic Patients with Cancer. Cancer Investigation 15:3, pages 237-242.
Read now
Read now
C. Teinturier, O. Hartmann, J. Lemerle, E. Benhamou & D. Maraninchi. (1995) Prevention of Gram-Positive Infections in Patients Treated with High-Dose Chemotherapy and Bone Marrow Transplantation: A Randomized Controlled Trial of Vancomycin. Pediatric Hematology and Oncology 12:1, pages 73-77.
Read now
Read now
Articles from other publishers (59)
Luke H. L’heureux & Elie M. Ferneini. 2016. Head, Neck, and Orofacial Infections. Head, Neck, and Orofacial Infections
406
415
.
Nisha Pherwani, Joanna M. Ghayad, Lisa M. Holle & Emilie L. Karpiuk. (2015) Outpatient management of febrile neutropenia associated with cancer chemotherapy: Risk stratification and treatment review. American Journal of Health-System Pharmacy 72:8, pages 619-631.
Crossref
Crossref
Jane L. Liesveld, Philip Rubin & Louis S. Constine. 2014. ALERT • Adverse Late Effects of Cancer Treatment. ALERT • Adverse Late Effects of Cancer Treatment
623
655
.
Miguel Salavert & Eva Calabuig. (2010) Papel de la daptomicina en el tratamiento de las infecciones en el paciente oncohematológico. Medicina Clínica 135, pages 36-47.
Crossref
Crossref
Ajay Gupta, Chetanya Swaroop, Sandeep Agarwala, Ravindra Mohan Pandey & Sameer Bakhshi. (2009) Randomized Control Trial Comparing Oral Amoxicillin-clavulanate and Ofloxacin With Intravenous Ceftriaxone and Amikacin as Outpatient Therapy in Pediatric Low-risk Febrile Neutropenia. Journal of Pediatric Hematology/Oncology 31:9, pages 635-641.
Crossref
Crossref
Nirmala Devi Baskaran, Gin Gin Gan & Kamarulzaman Adeeba. (2008) Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients. Annals of Hematology 87:7, pages 563-569.
Crossref
Crossref
Helen Innes, Sheow Lei Lim, Allison Hall, Su Yin Chan, Neeraj Bhalla & Ernest Marshall. (2007) Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice. Supportive Care in Cancer 16:5, pages 485-491.
Crossref
Crossref
Alison Freifeld, Jayashri Sankaranarayanan, Fred Ullrich & Junfeng Sun. (2007) Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA. Supportive Care in Cancer 16:2, pages 181-191.
Crossref
Crossref
Anastasia Antoniadou & Helen Giamarellou. (2007) Fever of Unknown Origin in Febrile Leukopenia. Infectious Disease Clinics of North America 21:4, pages 1055-1090.
Crossref
Crossref
Helen Innes & Ernie Marshall. (2007) Outpatient therapy for febrile neutropenia. Current Opinion in Oncology 19:4, pages 294-298.
Crossref
Crossref
Anastasia Antoniadou & Helen Giamarellou. 2007. Fever of Unknown Origin. Fever of Unknown Origin
35
58
.
H.C. Schouten. (2006) Neutropenia management. Annals of Oncology 17, pages x85-x89.
Crossref
Crossref
H Innes, L Billingham, C Gaunt, N Steven & E Marshall. (2005) Management of febrile neutropenia in the United Kingdom: time for a national trial?. British Journal of Cancer 93:12, pages 1324-1328.
Crossref
Crossref
Georgios Chamilos, Aristotle Bamias, Eleni Efstathiou, Pagona M. Zorzou, Efstathios Kastritis, Evagelos Kostis, Christos Papadimitriou & Meletios A. Dimopoulos. (2005) Outpatient treatment of low‐risk neutropenic fever in cancer patients using oral moxifloxacin. Cancer 103:12, pages 2629-2635.
Crossref
Crossref
H E Innes, D B Smith, S M O'Reilly, P I Clark, V Kelly & E Marshall. (2003) Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study. British Journal of Cancer 89:1, pages 43-49.
Crossref
Crossref
Der-Cherng Liang. (2003) The Role of Colony-Stimulating Factors and Granulocyte Transfusion in Treatment Options for Neutropenia in Children with Cancer. Pediatric Drugs 5:10, pages 673-684.
Crossref
Crossref
Fausto de Lalla. (2003) Outpatient Therapy for Febrile Neutropenia. PharmacoEconomics 21:6, pages 397-413.
Crossref
Crossref
Elmar Orudjev & Beverly J. Lange. (2002) Evolving concepts of management of febrile neutropenia in children with cancer. Medical and Pediatric Oncology 39:2, pages 77-85.
Crossref
Crossref
Kathleen Shannon-Dorcy. (2002) Nursing Implications of Mylotarg®: A Novel Antibody-Targeted Chemotherapy for CD33+Acute Myeloid Leukemia in First Relapse. Oncology Nursing Forum 29:4, pages E52-E59.
Crossref
Crossref
M. Wilhelm, W. Hiddemann, G. Maschmeyer, H. Link, D. Buchheidt, B. Glass, O. Cornely, M. Helmerking & D. Adam. 2001. Acute Leukemias VIII. Acute Leukemias VIII
324
329
.
Kenneth V.I. Rolston. (2000) Prediction of neutropenia. International Journal of Antimicrobial Agents 16:2, pages 113-115.
Crossref
Crossref
Jerry L. Shenep. (2000) Outpatient management of the neutropenic child with unexplained fever. Seminars in Pediatric Infectious Diseases 11:2, pages 105-112.
Crossref
Crossref
Victor M. Aquino, Larry Herrera, Eric S. Sandler & George R. Buchanan. (2000) Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer 88:7, pages 1710-1714.
Crossref
Crossref
Winfried V. Kern, Alain Cometta, Robrecht de Bock, John Langenaeken, Marianne Paesmans, Giorgio Zanetti, Thierry Calandra, Michel P. Glauser, Françoise Crokaert, Jean Klastersky, Athanasios Skoutelis, Harry Bassaris, Stephen H. Zinner, Claudio Viscoli, Dan Engelhard, Andrew Padmos & Harold Gaya. (1999) Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy. New England Journal of Medicine 341:5, pages 312-318.
Crossref
Crossref
Alison Freifeld, Donna Marchigiani, Thomas Walsh, Stephen Chanock, Linda Lewis, John Hiemenz, Sharon Hiemenz, Jeanne E. Hicks, Vee Gill, Seth M. Steinberg & Philip A. Pizzo. (1999) A Double-Blind Comparison of Empirical Oral and Intravenous Antibiotic Therapy for Low-Risk Febrile Patients with Neutropenia during Cancer Chemotherapy. New England Journal of Medicine 341:5, pages 305-311.
Crossref
Crossref
Eufemia Jacob. (1999) Making the transition from hospital to home: Caring for the newly diagnosed. Home Care Provider 4:2, pages 67-73.
Crossref
Crossref
Klaus J. Schnake, Paul H. Sugarbaker & Dal Yoo. (2018) Neutropenia following Perioperative Intraperitoneal Chemotherapy. Tumori Journal 85:1, pages 41-46.
Crossref
Crossref
Edward B Rubenstein, Linda S. Elting, Charlotte C. Sun & Kenneth V. I. Rolston. 1999. Clinical Applications of Cytokines and Growth Factors. Clinical Applications of Cytokines and Growth Factors
159
177
.
Diane D Davis & Marsha A Raebel. (2016) Ambulatory Management of Chemotherapy-Induced Fever and Neutropenia in Adult Cancer Patients. Annals of Pharmacotherapy 32:12, pages 1317-1323.
Crossref
Crossref
K. V. I. Rolston. (1998) Risk assessment and risk-based therapy in febrile neutropenic patients. European Journal of Clinical Microbiology & Infectious Diseases 17:7, pages 461-463.
Crossref
Crossref
Ricardo A. Durlach. (1998) Risk assessment during episodes of neutropenia and fever in the post-chemotherapy cancer patient. Antimicrobics and Infectious Diseases Newsletter 17:5, pages 33-38.
Crossref
Crossref
Athena Stoupis & Stephen H. Zinner. 1998. Management of Infectious Complications in Cancer Patients. Management of Infectious Complications in Cancer Patients
77
104
.
Victor M. Aquino, George R. Buchanan, Isabelle Tkaczewski & Mahmoud M. Mustafa. (1997) Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia. Medical and Pediatric Oncology 28:3, pages 191-195.
Crossref
Crossref
Carmen P. Escalante, Edward B. Rubenstein & Kenneth V. I. Rolston. (1996) Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients. Supportive Care in Cancer 4:5, pages 358-363.
Crossref
Crossref
Kenneth V. I. Rolston & Edward B. Rubenstein. (2017) Early Empiric Antibiotic Therapy for Febrile Neutropenia Patients at Low Risk. Cancer Control 3:4, pages 366-374.
Crossref
Crossref
Kenneth V.I. Rolston, Edward B. Rubenstein & Alison Freifeld. (1996) EARLY EMPIRIC ANTIBIOTIC THERAPY FOR FEBRILE NEUTROPENIA PATIENTS AT LOW RISK. Infectious Disease Clinics of North America 10:2, pages 223-237.
Crossref
Crossref
Peter Mauch, Louis Constine, Joel Greenberger, William Knospe, Jessie Sullivan, Jane L. Liesveld & H.Joachim Deeg. (1995) Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy. International Journal of Radiation Oncology*Biology*Physics 31:5, pages 1319-1339.
Crossref
Crossref
James S. Wohl & Susan M. Cotter. (2007) Approach To Complications Of Anti‐Cancer Therapy In Emergency Practice. Journal of Veterinary Emergency and Critical Care 5:1, pages 61-76.
Crossref
Crossref
Helen Giamarellou. (1995) Empiric therapy for infections in the febrile, neutropenic, compromised host. Medical Clinics of North America 79:3, pages 559-580.
Crossref
Crossref
E.B. Rubenstein & K.V.I. Rolston. (1995) Outpatient treatment of febrile neutropenic patients with cancer. European Journal of Cancer 31:1, pages 2-4.
Crossref
Crossref
W. Hiddemann. 1995. Therapie innerer Krankheiten. Therapie innerer Krankheiten
580
586
.
Edward B. Rubenstein & Kenneth Rolston. (1994) Outpatient management of febrile episodes in neutropenic cancer patients. Supportive Care in Cancer 2:6, pages 369-373.
Crossref
Crossref
P. Kumar & G.C. Jagetia. (1994) A review of triage and management of burns victims following a nuclear disaster. Burns 20:5, pages 397-402.
Crossref
Crossref
Robert O. Bash, Julie A. Katz, Jayne V. Cash & George R. Buchanan. (1994) Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia. Cancer 74:1, pages 189-196.
Crossref
Crossref
E Bouffet, C Fuhrmann, D Frappaz, D Couillioud, V Artiges, C Charra, D Bouhour & M Brunat Mentigny. (1994) Once daily antibiotic regimen in paediatric oncology.. Archives of Disease in Childhood 70:6, pages 484-487.
Crossref
Crossref
S. Marie, P. J. Broek, R. Willemze & R. Furth. (1993) Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination. European Journal of Clinical Microbiology & Infectious Diseases 12:12, pages 897-906.
Crossref
Crossref
E. Bouffet, C. Fuhrmann, D. Frappaz, C. Berger, D. Couilloud, D. Bouhour, M. Brunat-Mentigny & T. Philip. (1993) Etude clinique, bactériologique et pharmacocinétique de l'amikacine en dose unique journalière en oncologie pédiatrique. Médecine et Maladies Infectieuses 23, pages 55-59.
Crossref
Crossref
Miriam Weinberger. (1993) Approach to Management of Fever and Infection in Patients with Primary Bone Marrow Failure and Hemoglobinopathies. Hematology/Oncology Clinics of North America 7:4, pages 865-885.
Crossref
Crossref
Alison G. Freifeld. (1993) The Antimicrobial Armamentarium. Hematology/Oncology Clinics of North America 7:4, pages 813-839.
Crossref
Crossref
. (1993) Infection in the cancer patient. Disease-a-Month 39:7, pages 510-569.
Crossref
Crossref
Edward B Rubenstein, Kenneth Rolston, Carmen Escalante, Ellen Manzullo, Pamela Hughes, Andrew Fender, Linda Elting, Gerald P. Bodey, Frankie Holmes, John Loewy, Betty Moreland, Kathryn Kennedy & Robert S. Benjamin. (1993) Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 71:11, pages 3640-3646.
Crossref
Crossref
Uriel Bachrach, Anil K. Saxena, Mridula Saxena, R. Leurs, H. Timmerman, Betty Lee, Thomas L. Ciardelli, Maurizio Margaglione, Elvira Grandone, Giovanni Di Minno, Richard M. Schultz, V. P. Whittake, P. T. Männistö, I. Ulmanen, K. Lundström, J. Taskinen, J. Tenhunen, C. Tilgmann, S. Kaakkola & William J. WechterRichard M. Schultz. 1992. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques
219
250
.
Julie A. Katz, Robert Bash, Nancy Rollins, Jayne Cash & George R. Buchanan. (1991) The yield of routine chest radiography in children with cancer hospitalized for fever and neutropenia. Cancer 68:5, pages 940-943.
Crossref
Crossref
Carol McManus Balmer. (2016) Clinical Use of Biologic Response Modifiers in Cancer Treatment: An Overview Part II. Colony-Stimulating Factors and Interleukin-2. DICP 25:5, pages 490-498.
Crossref
Crossref
W. Hiddemann. 1991. Therapie innerer Krankheiten. Therapie innerer Krankheiten
418
423
.
R Liang, R Yung, E Chiu, P Y Chau, T K Chan, W K Lam & D Todd. (1990) Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.. Antimicrobial Agents and Chemotherapy 34:7, pages 1336-1341.
Crossref
Crossref
A. M. Marmont, E. A. McCulloch, J. K. H. Rees, P. Reizenstein & P. H. WiernikJohn Kempton Harold Rees. 1990. New Approaches to the Treatment of Leukemia. New Approaches to the Treatment of Leukemia
5
77
.
M. Rubin, T. Walsh, K. Butler, J. Lee, J. Lecciones, M. Weinberger, E. Roilides, J. Gress, D. Marshall & P. A. Pizzo. 1990. Acute Leukemias II. Acute Leukemias II
531
538
.
H. Koeppler, K. H. Pflueger, R. Seitz & K. Havemann. (1989) Three-step empiric treatment for severely neutropenic patients with fever: Ceftazidime — Vancomycin — Amphotericin BStufenweise, empirische Behandlung von neutropenischen Patienten mit Fieber: Ceftazidim — Vancomycin — Amphotericin B. Infection 17:3, pages 142-145.
Crossref
Crossref